Aflac Incorporated (NYSE:AFL) Position Increased by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC lifted its position in Aflac Incorporated (NYSE:AFL) by 39.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,488 shares of the financial services provider’s stock after acquiring an additional 3,839 shares during the period. Fidelis Capital Partners LLC’s holdings in Aflac were worth $1,205,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Y.D. More Investments Ltd acquired a new stake in Aflac during the 2nd quarter valued at $25,000. Atwood & Palmer Inc. grew its holdings in shares of Aflac by 80.0% during the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after buying an additional 140 shares in the last quarter. OFI Invest Asset Management acquired a new position in Aflac during the first quarter valued at $29,000. Dixon Mitchell Investment Counsel Inc. purchased a new stake in Aflac in the 1st quarter worth about $34,000. Finally, Cedar Wealth Management LLC acquired a new stake in Aflac during the 1st quarter worth about $50,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Up 0.0 %

Shares of AFL stock opened at $107.92 on Friday. The company has a market capitalization of $61.32 billion, a price-to-earnings ratio of 11.91, a PEG ratio of 2.53 and a beta of 0.95. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The stock’s 50 day simple moving average is $102.88 and its 200 day simple moving average is $91.96. Aflac Incorporated has a twelve month low of $74.89 and a twelve month high of $111.14.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. Aflac’s revenue for the quarter was down .7% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. As a group, research analysts predict that Aflac Incorporated will post 6.75 EPS for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.85%. Aflac’s payout ratio is presently 22.08%.

Wall Street Analyst Weigh In

AFL has been the topic of a number of research reports. JPMorgan Chase & Co. upped their target price on Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a report on Tuesday, July 2nd. Morgan Stanley upped their price objective on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research note on Monday, August 19th. Piper Sandler increased their target price on shares of Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, June 28th. Jefferies Financial Group lowered their price target on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a report on Friday, June 28th. Finally, Truist Financial increased their price objective on Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $92.50.

Insider Buying and Selling

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.90% of the stock is owned by insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.